Interstitial Lung Diseases in Respiratory ICU

Factors Affecting Outcome of Patients With Interstitial Lung Diseases in Respiratory Intensive Care Unit

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07117253

Enrollment

Registered

2025-08-12

Start date

2025-08-01

Completion date

2026-08-29

Last updated

2025-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interstitial Lung Diseases

Keywords

interstitial lung diseases, outcome in icu

Brief summary

This is Prospective observational study to analyze the clinical features, risk factors, outcome,mortality rates in interstitial lung diseases patients who required admission in Respiratory ICU

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patients who had diagnosis of interstitial lung diseases required admission in respiratory ICU

Exclusion criteria

* Patients with respiratory diseases other than ILD

Design outcomes

Primary

Measure	Time frame
Number of participants with Complications of disease	1 month after icu admission
Evaluate Length of respiratory ICU stay	1 month after icu admission
Assess mortality of patients with interstitial lung diseases in respiratory icu.	1 month after icu admission

Contacts

Primary Contactyasmine mamdouh salah, resident

yasmne_mamouh_post@med.sohag.edu.eg+201092243838

Outcome results